Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355075) titled 'A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)' on Jan. 19.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Turn Therapeutics
Condition:
Eczema Atopic Dermatitis
Eczema
Atopic Dermatitis
Intervention:
Combination Product: GX-03
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: July 11, 2025
Target Sample Size: 100
Countries of Recruitment:
United States
To k...